Cart
sales@molnova.com
VVD-130037
CAS No. 3034880-93-5
VVD-130037( —— )
Catalog No. M37603 CAS No. 3034880-93-5
VVD-130037 is a small molecule activator specifically targeting Kelch-like ECH-associated protein 1 (KEAP1) with potential antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 360 | In Stock |
|
| 5MG | 330 | In Stock |
|
| 10MG | 489 | In Stock |
|
| 25MG | 782 | In Stock |
|
| 50MG | 1014 | In Stock |
|
| 100MG | 1386 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVVD-130037
-
NoteResearch use only, not for human use.
-
Brief DescriptionVVD-130037 is a small molecule activator specifically targeting Kelch-like ECH-associated protein 1 (KEAP1) with potential antitumor activity.
-
DescriptionVVD-130037 is a small molecule activator specifically targeting Kelch-like ECH-associated protein 1 (KEAP1) with potential antitumor activity.VVD-130037 inhibits tumor growth in advanced solid tumors by degrading NRF2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNuclear Receptor/Transcription Factor
-
TargetKeap1-Nrf2
-
RecptorNrf2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3034880-93-5
-
Formula Weight344.8
-
Molecular FormulaC17H17ClN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C=C)(=O)N1[C@@H](COCC1)C2=CC(=CC(Cl)=C2)C=3N=C(N)C=CN3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
KI696
KI696 is a high-affinity probe that potently inhibits the interaction of Keap1 and NRF2.
-
2-tert-Butyl-1,4-ben...
2-tert-Butyl-1,4-benzoquinone (TBQ), an electrophilic metabolite of butylated hydroxyanisole (BHA), causes activation of Nrf2 together with S-arylation of its negative regulator Keap1 in RAW264.7 cells.
-
Eriodictyol-7-O-gluc...
Eriodictyol-7-O-glucoside is an Nrf2 activator conferring protection against Cisplatin-induced toxicity.
